This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Biotech Trades for Second Half of 2011

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Transcept Pharmaceuticals (TSPT - Get Report)
The event: FDA approval decision for Intermezzo, a sleeping pill designed for people who wake up in the middle of the night.
The timeline: The FDA approval decision is expected on or before July 14.
The stakes: Intermezzo's active ingredient is the same as what's found in the popular sleeping pill Ambien although at a lower dose and formulated to dissolve easily under the tongue. What makes Intermezzo unique and somewhat risky is the proposed indication as the first-of-its-kind prescription sleep aid for people who wake in the middle of the night but cannot fall back to sleep. To get Intermezzo approved, Transcept must convince the FDA that the drug can be packaged and used correctly to reduce the risk of dosing errors or impaired next-day driving ability.

8 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
BPAX $55.05 -1.24%
TSPT $28.87 -1.06%
EXEL $3.08 0.00%
GILD $103.70 0.00%
ONTY $1.74 0.00%


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs